Alcaino J, Vera G, Almarza G, Lagos C, Terraza C, Del Campo A
Sci Rep. 2025; 15(1):8380.
PMID: 40069248
PMC: 11897353.
DOI: 10.1038/s41598-025-92755-6.
Costa V, Motta F, Dos Santos Carvalho A, Mendonca de Melo F, Mottin M, Charneau S
J Chem Inf Model. 2025; 65(5):2636-2649.
PMID: 40007463
PMC: 11898053.
DOI: 10.1021/acs.jcim.4c02152.
Patil S, Kuehn B, McCullough C, Bates D, Hazim H, Diallo M
Molecules. 2025; 30(4).
PMID: 40005250
PMC: 11858207.
DOI: 10.3390/molecules30040940.
Schoenmaker L, Jiskoot D, Scheen J, Cheng E, Gapsys V, Hahn D
J Phys Chem B. 2025; 129(9):2370-2379.
PMID: 39976528
PMC: 11891892.
DOI: 10.1021/acs.jpcb.4c07156.
Ireland D, Rabeler C, Rao S, Richardson R, Collins E
PLoS One. 2025; 20(1):e0315394.
PMID: 39883642
PMC: 11781733.
DOI: 10.1371/journal.pone.0315394.
Design, synthesis, and biological evaluation of insect hormone agonists.
Yokoi T
J Pestic Sci. 2025; 49(4):303-310.
PMID: 39877879
PMC: 11770153.
DOI: 10.1584/jpestics.J24-02.
Towards New Scaffolds for Antimicrobial Activity-In Silico/In Vitro Workflow Introducing New Lead Compounds.
Mangana M, Lambrinidis G, Kostakis I, Kalpaktsi I, Sagnou M, Nicolaou C
Antibiotics (Basel). 2025; 14(1).
PMID: 39858297
PMC: 11763081.
DOI: 10.3390/antibiotics14010011.
The algebraic extended atom-type graph-based model for precise ligand-receptor binding affinity prediction.
Mukta F, Rana M, Meyer A, Ellingson S, Nguyen D
J Cheminform. 2025; 17(1):10.
PMID: 39844277
PMC: 11756177.
DOI: 10.1186/s13321-025-00955-z.
Identification of Novel Human 15-Lipoxygenase-2 (h15-LOX-2) Inhibitors Using a Virtual Screening Approach.
Viviani L, Iijima T, Piccirillo E, Rezende L, Alegria T, Netto L
J Med Chem. 2024; 68(1):307-323.
PMID: 39700339
PMC: 11726667.
DOI: 10.1021/acs.jmedchem.4c01884.
Combining crystallographic and binding affinity data towards a novel dataset of small molecule overlays.
Honig S, Gutermuth T, Ehrt C, Lemmen C, Rarey M
J Comput Aided Mol Des. 2024; 39(1):2.
PMID: 39630291
PMC: 11618164.
DOI: 10.1007/s10822-024-00581-1.
Rational Approach to New Chemical Entities with Antiproliferative Activity on Ab1 Tyrosine Kinase Encoded by the Gene: An Hierarchical Biochemoinformatics Analysis.
Sanches V, Lobato C, Silva L, Dos Santos I, Barros E, Maciel A
Pharmaceuticals (Basel). 2024; 17(11).
PMID: 39598402
PMC: 11597596.
DOI: 10.3390/ph17111491.
vScreenML v2.0: Improved Machine Learning Classification for Reducing False Positives in Structure-Based Virtual Screening.
Andrianov G, Haroldsen E, Karanicolas J
Int J Mol Sci. 2024; 25(22).
PMID: 39596415
PMC: 11595162.
DOI: 10.3390/ijms252212350.
Characterization of novel small molecule inhibitors of estrogen receptor-activation function 2 (ER-AF2).
Foo J, Gentile F, Massah S, Morin H, Singh K, Lee J
Breast Cancer Res. 2024; 26(1):168.
PMID: 39593108
PMC: 11590367.
DOI: 10.1186/s13058-024-01926-2.
Building shape-focused pharmacophore models for effective docking screening.
Moyano-Gomez P, Lehtonen J, Pentikainen O, Postila P
J Cheminform. 2024; 16(1):97.
PMID: 39123240
PMC: 11312248.
DOI: 10.1186/s13321-024-00857-6.
Discovery of Novel, Selective, and Nonbasic Agonists for the Kappa-Opioid Receptor Determined by Salvinorin A-Based Virtual Screening.
Puls K, Olive-Marti A, Hongnak S, Lamp D, Spetea M, Wolber G
J Med Chem. 2024; 67(16):13788-13801.
PMID: 39088801
PMC: 11345774.
DOI: 10.1021/acs.jmedchem.4c00590.
MAGPIE: An interactive tool for visualizing and analyzing protein-ligand interactions.
Rodriguez D, Weber K, Sundberg B, Glasgow A
Protein Sci. 2024; 33(8):e5027.
PMID: 38989559
PMC: 11237554.
DOI: 10.1002/pro.5027.
Scaffold-Hopped Compound Identification by Ligand-Based Approaches with a Prospective Affinity Test.
Maeda I, Tamura S, Ogura Y, Serizawa T, Shimada T, Kunimoto R
J Chem Inf Model. 2024; 64(14):5557-5569.
PMID: 38950192
PMC: 11267578.
DOI: 10.1021/acs.jcim.4c00342.
Development of a novel representation of drug 3D structures and enhancement of the TSR-based method for probing drug and target interactions.
Milon T, Wang Y, Fontenot R, Khajouie P, Villinger F, Raghavan V
Comput Biol Chem. 2024; 112:108117.
PMID: 38852360
PMC: 11390338.
DOI: 10.1016/j.compbiolchem.2024.108117.
Selective and brain-penetrant ACSS2 inhibitors target breast cancer brain metastatic cells.
Esquea E, Ciraku L, Young R, Merzy J, Talarico A, Ahmed N
Front Pharmacol. 2024; 15:1394685.
PMID: 38818373
PMC: 11137182.
DOI: 10.3389/fphar.2024.1394685.
A Hybrid Approach Combining Shape-Based and Docking Methods to Identify Novel Potential P2X7 Antagonists from Natural Product Databases.
da Silva Ferreira N, Viviani L, Lima L, Amaral A, Romano J, Fortunato A
Pharmaceuticals (Basel). 2024; 17(5).
PMID: 38794162
PMC: 11123696.
DOI: 10.3390/ph17050592.